- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CDSCO directs to mark Doping Drug Labels with either vertical Orange line or line of any other colour: Report
These medicines are scheduled formulations and are prescribed for certain conditions under the supervision of registered medical practitioners and are supposed to be given in the right dosages. However, it has been noticed that these medicines are being consumed by athletes, gym-going people etc., without any prescriptions.
New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has suggested that labels of all doping drugs which are banned by World Anti-Doping Agency (WADA) and National Anti-Doping Agency (NADA) should be marked with either a vertical "Orange" line or a line of any other colour line. This will make it easy and convenient to identify and to ensure that these drugs are not used without medical supervision/advice, reports Express Pharma.
In this regard, CDSCO has directed the pharma stakeholders to submit their suggestions on doping drug (performance-enhancing drugs) labels. It has also stressed that the suggestions should be made after taking visually impaired persons into consideration and should be user friendly.
The concern was discussed on a virtual meeting held on June 23, 2020, at the CDSCO office, chaired by A K Pardhan, DDC (I) and attended by key industry stakeholders.
During the meeting, Pradhan informed that the CDSCO office has received representations from general public and Prime Minister Office Grievance cell seeking formulation of guidelines for labelling of performance-enhancing drugs (doping drugs).
These medicines are scheduled formulations and are prescribed for certain conditions under the supervision of registered medical practitioners and are supposed to be given in the right dosages. However, it has been noticed that these medicines are being consumed by athletes, gym-going people etc., without any prescriptions.
Also Read: CDSCO Issues Clarification On Import Of Diagnostic Kits, Reagents For Research Use Only
CDSCO also stated that the list of doping drugs which are banned by World Anti-Doping Agency (WADA) and National Anti-Doping Agency (NADA) should be made available to the public, teachers, parents, students, sportspersons, doctors etc. for their knowledge.
He also recommended that the labels of all such drugs should be marked with either a vertical "Orange" line or a line of any other colour line for easy and convenient identification and to ensure that these drugs are not used without medical supervision/advice.
The matter will be placed before the Drugs Technical Advisory Board (DTAB) and they will prepare draft guidelines. The doping drug list may be put in the public domain for the knowledge of the public as well as for medical professionals, etc. and an awareness campaign may be undertaken to avoid misuse of such drugs, reports Express Pharma.
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751